MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial-Reference-Cited by-同舟云学术

MATRix–RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial

Published:2021-02 Issue:2 Volume:8 Page:e110-e121
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Ferreri Andrés J M,Doorduijn Jeanette K,Re Alessandro,Cabras Maria Giuseppina,Smith Jeffery,Ilariucci Fiorella,Luppi Mario,Calimeri Teresa,Cattaneo Chiara,Khwaja Jahanzaib,Botto Barbara,Cellini Claudia,Nassi Luca,Linton Kim,McKay Pam,Olivieri Jacopo,Patti Caterina,Re Francesca,Fanni Alessandro,Singh Vikram,Bromberg Jacoline E C,Cozens Kelly,Gastaldi Elisabetta,Bernardi Massimo,Cascavilla Nicola,Davies Andrew,Fox Christopher P,Frezzato Maurizio,Osborne Wendy,Liberati Anna Marina,Novak Urban,Zambello Renato,Zucca Emanuele,Cwynarski Kate

Funder

Cancer Research UK

Publisher

Elsevier BV

Subject

Hematology

Reference22 articles.

1. Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma;El-Galaly;Eur J Cancer,2018

2. Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial;Gleeson;Ann Oncol,2017

3. Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL;Klanova;Blood,2019

4. Natural history of CNS relapse in patients with aggressive non-Hodgkin's lymphoma: a 20-year follow-up analysis of SWOG 8516—the Southwest Oncology Group;Bernstein;J Clin Oncol,2009

5. Central nervous system recurrence of systemic lymphoma in the era of stem cell transplantation—an International Primary Central Nervous System Lymphoma Study Group project;Bromberg;Haematologica,2013

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human immunodeficiency virus-associated lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Annals of Oncology;2024-10

2. CNS prophylaxis in large B‐cell lymphomas: A balance with three pans;British Journal of Haematology;2024-09-14

3. Human immunodeficiency virus‐associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up;HemaSphere;2024-09

4. Unmet Needs in the First-Line Treatment of Diffuse Large B-cell Lymphoma: Expert Recommendations From the Asia-Pacific Region With a Focus on the Challenging Subtypes;Clinical Lymphoma Myeloma and Leukemia;2024-09

5. Identification, risk factors, and clinical course of CNS relapse in DLBCL patients across 19 prospective phase 2 and 3 trials—a LYSA and GLA/ DSHNHL collaboration;Leukemia;2024-08-16